• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences

    Abiomed Leader Michael Minogue Named AdvaMed Board Chairman

    TransEnterix Changes Name to Asensus Surgical

    Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test

    NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Medicoil

    Spectrum Plastics Group

    Forefront Medical Technology

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud

    Evolving Trends in the Medical and Orthopedic Devices Industry
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    Unicep

    Concise Engineering

    MW Life Sciences
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    12. Danaher

    ...

    12. Danaher
    Related CONTENT
    • The 2019 Top 30 Global Medical Device Companies
    • Catching Its Breath: Observations from the 2019 Top Companies Reports
    • The 2019 Top 30 Global Medical Device Companies
    • 2. Johnson & Johnson
    • 3. GE Healthcare
    07.30.19
    AT A GLANCE
    Rank: #12 (Last year: #13)
    $9.10 Billion ($19.9B total)
    Prior Fiscal: $8.60 Billion
    Percentage Change: +5.81%
    No. of Employees: 71,000 (total)
    Global Headquarters: Washington, D.C.

    KEY EXECUTIVES
    Thomas P. Joyce Jr., President and CEO
    Matthew R. McGrew, Exec. VP and CFO
    Brian W. Ellis, Sr. VP and General Counsel
    William H. King, Sr. VP, Strategic Development
    Robert S. Lutz, Sr. VP and Chief Accounting Officer
    Daniel A. Raskas, Sr. VP, Corporate Development
    Chris Riley, President, Beckman Coulter Diagnostics
    Matt Turner, President, Ormco
    Christophe Duret, President, HemoCue
    Markus Lusser, President, Leica Microsystems
    Susan Murphy, President, Molecular Devices
    Jennifer Honeycutt, President, Pall
    Inese Lowenstein, President, SCIEX
    Hans Geiselhöringer, President, Nobel Biocare

    Westslope cutthroats run big in the South Fork. So do bull trout, which can grow as large as 25 pounds from a steady diet of scuds, minnows, mayflies (depending on river currents), kokanee (a.k.a., sockeye) salmon, and, ironically enough, cutthroats.

    Trout bite all year long in the South Fork. Big Sky biologists say the river contains 400 to 1,000 fish per mile, with cutthroats ranging from 12 to 18 inches and bulls averaging more than 20 inches (some can reportedly reach two and a half feet!). It’s not unusual to find larger-than-normal fish in this part of North America, as the cool, nutrient-rich water flow from mountain streams creates an ideal breeding ground for trout prey. These food factories are often so prolific that trout can get bigger simply by staying in one spot and feeding on their surroundings.

    The 98-mile South Fork of western Montana’s majestic Flathead River begins deep within the Bob Marshall Wilderness Complex, a 1.53 million-acre tract of Congressionally-designated wild land flanking the Continental Divide. The South Fork begins at the junction of Danaher and Young’s creeks; fed by dozens of small tributaries, it runs for 45 miles due north before exiting The Bob near Spotted Bear Ranger Station.

    South Fork is the site of the world’s highest morning glory spillway (water cascades 490 feet off the 66-year-old Hungry Horse Dam). It’s also the site of inspiration for Steven and Mitchell Rales’ entrepreneurial aspirations: During an early 1980s fishing trip on the river, the Bethesda, Md., brothers envisioned starting a new kind of manufacturing company—an entity committed to continuous improvement and customer satisfaction. Using their favorite fishing spot as a muse, the Rales decided their organization would operate much like the South Fork: continuously moving forward but able to quickly change flow.

    The Rales’ new company began as a real estate investment trust but assumed its true mission after refocusing on manufacturing and adopting kaizen, the Japanese business philosophy of continuous improvement. In a nod to their muse, the brothers renamed the firm Danaher (quite appropriate, considering “dana” actually is an ancient Celtic word for “swift-flowing”).

    Danaher spent its formative years as a group of individual manufacturing businesses. Over the past quarter century, however, the Rales have become renowned for their unique approach to business growth; the strategy involved buying other companies’ discards and subjecting them to the Danaher Business System (a set of lean manufacturing and continuous improvement principles) to raise their margins and capital returns. That method has worked rather well for the company in its evolution into a multi-billion-dollar conglomerate with operations in life sciences, diagnostics, dental, environmental services, and industrial tools.

    “We have never strayed from the clarity of our intention or the inspiration of that swift-flowing river,” the company states in a brief autobiography on its home page. “We adapt quickly to the changing flow of business and the evolution of technology, but our guiding principles—continuous improvement and customer satisfaction—remain rock solid.”

    Those guiding principles, though, have largely dictated Danaher’s ever-changing business flow throughout its lifetime. Case in point: The company entered the medtech industry in the early part of the millennium to offset saturation and low growth rates in its capital-intensive and cyclical industrial platform. Upon diversifying its healthcare offerings (through acquisition), Danaher spun off its industrial businesses into an independent, publicly-traded firm (Fortive) focusing on professional instrumentation, automation, sensing, and transportation technologies.

    The Fortive spinoff turned Danaher into a predominantly healthcare-focused business with offerings in acute care, pathology diagnostics, life sciences instrumentation, and dental technology. The split also has created significant shareholder value for both companies—since the July 2016 breakup, Fortive and Danaher have provided total returns of nearly 70 percent and 61 percent, respectively, (through February this year).

    Sales and profits have benefitted from the spinoff as well: Fortive’s 2018 revenue grew 12 percent to $6.45 billion, and profits swelled 3.1 percent to $1.17 billion. First-quarter sales this year jumped 6.7 percent, with core revenues rising 3.7 percent. Danaher’s finances experienced a similar boost, with fiscal 2018 sales climbing 8.5 percent to $19.89 billion and profits surging 13.8 percent to $3.4 billion, according to the company’s 2018 annual report. First-quarter 2019 sales rose 3.9 percent and gross profit advanced 2.8 percent to $2.71 billion.

    The Rales brothers are hoping history repeats itself with the spinout of Danaher’s dental segment, announced last July. The dental unit has been a monetary millstone for the company in recent years due to inventory restocks and product manufacturing/distribution realignments. Dental segment revenue has barely moved since fiscal 2016, edging up only $59.1 million to $2.84 billion through Dec. 31, 2018. Operating profit, meanwhile, has nosedived, falling 4.4 percent in 2017 (to $400.7 million) and a staggering 13.5 percent last year to $346.7 million.

    “The dental unit has been a sore spot for Danaher amid otherwise strong organic growth and profitability,” Bloomberg opinion columnist Brooke Sutherland wrote upon learning of the spinoff. “Talking about and trying to fix that business sucked up an increasing amount of executives’ time. And while there are signs that efforts to cut costs and invest in new growth initiatives at the dental unit are yielding results, the turnaround efforts had undoubtedly become a distraction and both companies should be better off as separate entities.”

    Danaher executives agree. Commenting on the spinoff last summer, Danaher president/CEO Thomas Joyce Jr. predicted the move would cultivate more focused, savvy investments that eventually will boost long-term shareholder value for both companies.


    ANALYST INSIGHTS: Danaher is a company very adept at portfolio management. Watch for them to continue that focus with incremental M&A activities. Don’t be surprised if it decides to either make a large opportunistic acquisition or divest one of its current businesses or both. It’s a rare year when Danaher stands still.

    —Dave Sheppard, Co-Founder and Managing Advisor, MedWorld Advisors



    “This is an important step towards realizing even greater potential for both Danaher and our Dental business,” Joyce said. “[The] announcement demonstrates our commitment to maximizing long-term value for all of our shareholders, customers, and associates. We believe that our Dental business can be more effective as a standalone company, with greater focus around both organic and inorganic investment opportunities.”

    Danaher’s DentalCo (a new name is forthcoming) is expected to be completely free of its parent firm in the second half of 2019. The company will be tax free to shareholders and comprise the KaVo Kerr, Nobel Biocare, and Ormco businesses. It will employ 12,000 workers and be led by president/group executive Amir Aghdaei.

    DentalCo’s diverse product offerings should help the firm succeed upon its independence. All three business divisions debuted new innovations last year, beginning with the winter premiere of KaVo Kerr’s flexible digital intraoral X-ray sensor (DEXIS FS Ergo), X Pro intraoral scanner, and Dex Voice.

    Danaher branded the FS Ergo as a “new category” of intraoral sensors designed to improve patient comfort and diagnostic detail. The Dex Voice, unveiled at the 2018 Chicago Midwinter dental meeting, is built on the Amazon Echo/Alexa platform and fully integrates with the company’s Dexis software. Its smart speaker enables clinicians to deliver voice commands to Alexa to perform Dexis actions that normally would require keyboard or other manually entered commands.

    Over the summer, KaVo Kerr introduced a handheld X-ray system (the NOMAD Pro 2), cross-cut carbide burrs, a titanium sensor featuring motion detection capabilities, and a composite system (SonicFill 3) designed to fill cavities in seconds. The SonicFill 3 SingleFill system contains a nanoscale zirconsil (zirconium oxide plus silica oxide) composite filler, which provides effective blending, wear resistance, strength, and reliability for lasting restorations, according to Danaher.

    Nobel Biocare timed its only product launch for the summer as well, releasing to market a two-piece ceramic implant featuring a cement-free connection to support natural soft tissue appearance. Made of zirconia, the NobelPearl is designed to encourage excellent soft tissue attachment and minimize inflammation. The product is particularly useful in thin gingival biotype cases.

    Ormco debuted the bulk of its new technologies last spring and fall, including a ceramic twin bracket system, a self-litigating bracket (with twice the rotational control and more space under the tie-wing than its predecessor), and a line of stainless-steel instruments (45 pliers, 12 cutters).

    “We are building a better, stronger Danaher,” Joyce wrote in his annual shareholder letter last year. “With the Danaher Business System as our driving force, we strengthened our footholds in attractive, fast-growing markets and enhanced our competitive positions. We accelerated our core revenue growth rate, led primarily by the impact of new product innovation and sales and marketing initiatives. Financially and strategically, 2018 was an outstanding year.”

    Indeed, it was—for Danaher’s non-dental business segments. Sales in the company’s Life Sciences, Diagnostics, and Environmental & Applied Solutions units posted solid gains, rising 13.3 percent, 7.1 percent, and 8.8 percent, respectively.

    Diagnostics revenue, which totaled $6.25 billion, was fueled by strong growth in each product division. Molecular diagnostics, for example, experienced robust infectious disease commodity sales upon the outbreak of a severe flu season last winter as well as the additions of new assays to its portfolio. The unit’s Cepheid business won U.S. Food and Drug Administration (FDA) approval for rapid flu A/B, Strep A, and carbapenem non-susceptible bacteria tests, and CE IVD marking for Hepatitis B and Hepatitis C tests.

    Acute Care Diagnostics profited from strong sales of blood gas and immunoassay products across most major geographies, while new innovations in advanced staining and core histology bolstered Pathology Diagnostics sales.

    Clinical Lab Diagnostics proceeds rose on higher 2018 sales in China and stronger demand for immunoassay products. The business met that demand in part last year by commercializing solutions like Access Sensitive Estradiol, a test for measuring estradiol levels in blood (for diagnosing fertility, menstruation, or puberty problems).

    The E2 (estradiol) test was just one of a number of products the Clinical Lab Diagnostics business marketed last year (through Danaher’s Beckman Coulter Diagnostics arm). Other commercialized innovations included:
    • DxM 6100 Autoplak Advanced automated plate streaking system, a fully contained automated solution for boosting lab productivity, workflow, flexibility, and testing quality. The DxM 6100 automates and integrates core aspects of microbiology specimen processing, including plating and streaking, Gram stain slide preparation and enrichment broth inoculation. The solution streamlines routine tasks and helps laboratories manage increasing testing volumes by enabling them to reallocate technical resources as needed.
    • DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing that uses direct minimum inhibitory concentrations for antimicrobial resistance detection. Added workflow enhancements include a new fluid-level sensing technology, external LED indicators that show status at a glance, quick bottle release for simplifying reagent maintenance, and integrated reliability improvements to maximize uptime.
    • DxONE PROService, a custom remote service application that helps labs achieve fast turnaround times for patient test results through continuous instrument monitoring. The PROService allows Beckman Coulter to work in collaboration with labs to identify potential system issues with alerts for possible workflow disruptions.
    • DxH 900 hematology analyzer,  a device that gives mid- to high-volume clinical labs the ability to perform complete blood count and white blood cell differential tests with minimal repeats. Its core technologies—an enhanced Coulter Principle, VCS 360, and DataFusion—offer high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for red blood cell, platelet, and white blood cell test results on the first pass.
    In addition to commercialization efforts, Beckman Coulter secured CE mark approval for its Early Sepsis Indicator and DxH 520 Hematology analyzer. The Early Sepsis Indicator identifies patients who either have developed sepsis or are at risk of developing it. It is the first early sepsis warning test to be offered as part of a complete blood count with differential, according to the company. 

    The 520 Hematology analyzer is made to enhance doctor office laboratory efficiency and resource management through the automation of daily tasks. Using two aqueous-based cyanide-, azide- and formaldehyde-free reagents, the system reduces the amount of time spent on lab operations and frees up time for patient care.

    Two months after receiving the CE mark for the 520 Hematology analyzer Beckman Coulter scored a double regulatory victory in June 2018 with back-to-back clearances in Canada and the United States for its high-sensitivity troponin (hsTnl) assay, Access hsTn1, a test for detecting troponin l—a protein present in circulation during myocardial infarction. The FDA cleared the assay for use on the Access 2, DxI, and the entire Access family of immunoassay systems.
    Related Searches
    • handheld
    • sales
    • led
    • it
    Suggested For You
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    Catching Its Breath: Observations from the 2019 Top Companies Reports Catching Its Breath: Observations from the 2019 Top Companies Reports
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    2. Johnson & Johnson 2. Johnson & Johnson
    3. GE Healthcare 3. GE Healthcare
    18. 3M Health Care 18. 3M Health Care
    22. Dentsply Sirona 22. Dentsply Sirona
    23. Canon Medical Systems 23. Canon Medical Systems
    27. Hologic 27. Hologic
    29. Hillrom 29. Hillrom
    Bentec Medical Appoints New CEO Bentec Medical Appoints New CEO
    Beckman Coulter Introduces Total Laboratory Automation Solution Beckman Coulter Introduces Total Laboratory Automation Solution
    Beckman Coulter Beckman Coulter's Blood Test Analyzers Recalled Over Risk of Inaccurate Platelet Analyzing Results
    FDA OKs Beckman Coulter FDA OKs Beckman Coulter's Early Sepsis Indicator
    FDA Clears Beckman Coulter FDA Clears Beckman Coulter's Compact, Low-Volume Hematology Analyzer

    Related Top30

    • The 2020 Top 30 Global Medical Device Companies

      The 2020 Top 30 Global Medical Device Companies

      Leadership changes, divestments, and portfolio-building partnerships—through acquisition or collaboration—were common threads among medtech’s largest players.
      MPO Editors 07.21.20

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      ...
      07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19

    • 4. Abbott

      4. Abbott

      ...
      07.30.19


    • 5. Philips

      5. Philips

      ...
      07.30.19

    • 6. BD

      6. BD

      ...
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      ...
      07.30.19


    • 7. Siemens Healthineers

      7. Siemens Healthineers

      ...
      07.30.19

    • 9. Stryker

      9. Stryker

      ...
      07.30.19

    • 10. Baxter

      10. Baxter

      ...
      07.30.19


    • 11. Boston Scientific

      11. Boston Scientific

      ...
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      ...
      07.30.19

    • 14. Zimmer Biomet

      14. Zimmer Biomet

      ...
      07.30.19


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • FDA Approves Daytime Treatment For Sleep Apnea And Snoring
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Understanding Food-Grade Vs. Biocompatibility For Medical Device Materials
    Breaking News
    • Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    • Abiomed Leader Michael Minogue Named AdvaMed Board Chairman
    • TransEnterix Changes Name to Asensus Surgical
    • Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test
    • NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    Hempel Launches Sustainability Framework: Futureproof
    ChemQuest Hires Rich Gibson
    New Increase in Kynar Fluoropolymer Capacities at Arkema's Chinese Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences
    Abiomed Leader Michael Minogue Named AdvaMed Board Chairman
    TransEnterix Changes Name to Asensus Surgical
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Altasciences Contributes to Vibegron Approval
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Pfizer Selects Seven Bridges to Support RNA Sequencing Data
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Madison Reed Raises $52 Million in Financing Round
    The Estée Lauder Companies Closes Becca Cosmetics
    Afro Sheen Launches New Brand Initiatives
    Happi

    Latest Breaking News From Happi

    PBA Opposes House Bill 2325 in West Virginia
    J.R. Watkins Tackles Pain with New Lines
    RB Launches Vanish Miracle
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Eaglewood Technologies debuts new anilox cleaning system
    INX International and VerifyMe sign supply agreement
    Soma partners with DTM Flexo Services
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    H&V Announces Price Increase
    Fiber Bond VE3 Technology Inactivates SARS-CoV-2 in HVAC Filtration Systems
    Citizens Provides $325 Million Senior Credit Facility to Nice-Pak
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    NuVasive Nabs Simplify Medical for $150M
    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login